from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3371/-

LFCtreatmentdescriptionclass of inhibitor

1.374

Amikacinug/mL Amikacintranslation

1.314

Cap5-10ug/mL Capreomycintranslation

1.687

Rox10-50 ug/mL Roxithromycintranslation

0.230

SM2-5 ug/mL Streptomycintranslation

2.753

Tet5-10 ug/mL Tetracyclinetranslation

-1.182

Rif0.2-5ug/mL Rifampicintranscription

-0.567

Rifp0.1-0.5ug/mL Rifapentinetranscription

1.675

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.045

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.895

CPZ10-50 ug/mL Chlorpromazinerespiration

0.659

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.282

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.423

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.661

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.487

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.022

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.487

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

1.425

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.309

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.644

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.480

KCN5-20 ug/mL Potassium cyaniderespiration

-0.501

NaN30.2-2 mM Sodium aziderespiration

0.547

Nigericin50 uM Nigericinrespiration

-0.515

TRC10-150 ug/mL Triclosanrespiration

0.301

TRZ10-25 ug/mL Thioridazinerespiration

0.663

Valinomycin0.5-10 uM Valinomycinrespiration

-0.835

ZnSO42 mM ZnSO4respiration

1.271

menadione6-10 ug/mL Menadionerespiration

0.098

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.479

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.649

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.138

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

2.956

NRP_1Non-replicating persistence stage 1dosRassociated

0.020

Amp0.2mg/mL AmpicillincellWall

-0.342

Cephalexin20-100 ug/mL CephalexincellWall

0.013

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.743

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.232

EMB10-20 ug/mL EthambutolcellWall

0.357

Eta12-40 ug/mL EthionamidecellWall

0.304

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.101

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.276

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.741

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.750

BZA0.12 mg/mL BenzamidearomaticAmides

-0.978

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.971

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.942

H2O24 mM hydrogen peroxideDNAdamaging

-0.334

Levo10 ug/mL LevofloxacinDNAdamaging

-0.577

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.615

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.027

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.333

UVUV-irradiationDNAdamaging

0.335

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.510

Antimycin12.5-50 ug/mL Antimycin A?

-0.652

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.496

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.537

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.102

PA8240.2-2 ug/mL PA-824?

1.002

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.729

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.431

Verapamil50 uM Verapamil?

-0.710

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.496

methoxatin10-20 ug/mL Methoxatin?